Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asymmetric Unit
(-)Asym. Unit - sites
(-)Biological Unit 1
(-)Biol. Unit 1 - sites
(-)Biological Unit 2
collapse expand < >
Image Asymmetric Unit
Asymmetric Unit  (Jmol Viewer)
Image Asym. Unit - sites
Asym. Unit - sites  (Jmol Viewer)
Image Biological Unit 1
Biological Unit 1  (Jmol Viewer)
Image Biol. Unit 1 - sites
Biol. Unit 1 - sites  (Jmol Viewer)
Image Biological Unit 2
Biological Unit 2  (Jmol Viewer)

(-) Description

Title :  TRANYLCYPROMINE-INHIBITED HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH 2-(2-BENZOFURANYL)-2-IMIDAZOLINE
 
Authors :  D. Bonivento, E. M. Milczek, G. R. Mcdonald, C. Binda, A. Holt, D. E. Edmo A. Mattevi
Date :  23 Apr 10  (Deposition) - 06 Oct 10  (Release) - 24 Nov 10  (Revision)
Method :  X-RAY DIFFRACTION
Resolution :  1.90
Chains :  Asym. Unit :  A,B
Biol. Unit 1:  A,B  (1x)
Biol. Unit 2:  A,B  (2x)
Keywords :  Flavoprotein, Maob, Mitochondrion, Oxidoreductase, Transmembrane (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  D. Bonivento, E. M. Milczek, G. R. Mcdonald, C. Binda, A. Holt, D. E. Edmondson, A. Mattevi
Potentiation Of Ligand Binding Through Cooperative Effects In Monoamine Oxidase B.
J. Biol. Chem. V. 285 36849 2010
PubMed-ID: 20855894  |  Reference-DOI: 10.1074/JBC.M110.169482

(-) Compounds

Molecule 1 - AMINE OXIDASE [FLAVIN-CONTAINING] B
    ChainsA, B
    EC Number1.4.3.4
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    SynonymMONOAMINE OXIDASE TYPE B, MAO-B

 Structural Features

(-) Chains, Units

  12
Asymmetric Unit AB
Biological Unit 1 (1x)AB
Biological Unit 2 (2x)AB

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (4, 8)

Asymmetric Unit (4, 8)
No.NameCountTypeFull Name
13PL2Ligand/Ion3-PHENYLPROPANAL
2C152Ligand/IonN-DODECYL-N,N-DIMETHYL-3-AMMONIO-1-PROPANESULFONATE
3FA82Ligand/Ion[[(2R,3S,4S)-5-[(4AS)-7,8-DIMETHYL-2,4-DIOXO-4A,5-DIHYDROBENZO[G]PTERIDIN-10-YL]-2,3,4-TRIHYDROXY-PENTOXY]-HYDROXY-PHOSPHORYL] [(2R,3S,4R,5R)-5-(6-AMINOPURIN-9-YL)-3,4-DIHYDROXY-OXOLAN-2-YL]METHYLHYDROGEN PHOSPHATE
4XCG2Ligand/Ion2-(2-BENZOFURANYL)-2-IMIDAZOLINE
Biological Unit 1 (4, 8)
No.NameCountTypeFull Name
13PL2Ligand/Ion3-PHENYLPROPANAL
2C152Ligand/IonN-DODECYL-N,N-DIMETHYL-3-AMMONIO-1-PROPANESULFONATE
3FA82Ligand/Ion[[(2R,3S,4S)-5-[(4AS)-7,8-DIMETHYL-2,4-DIOXO-4A,5-DIHYDROBENZO[G]PTERIDIN-10-YL]-2,3,4-TRIHYDROXY-PENTOXY]-HYDROXY-PHOSPHORYL] [(2R,3S,4R,5R)-5-(6-AMINOPURIN-9-YL)-3,4-DIHYDROXY-OXOLAN-2-YL]METHYLHYDROGEN PHOSPHATE
4XCG2Ligand/Ion2-(2-BENZOFURANYL)-2-IMIDAZOLINE
Biological Unit 2 (4, 16)
No.NameCountTypeFull Name
13PL4Ligand/Ion3-PHENYLPROPANAL
2C154Ligand/IonN-DODECYL-N,N-DIMETHYL-3-AMMONIO-1-PROPANESULFONATE
3FA84Ligand/Ion[[(2R,3S,4S)-5-[(4AS)-7,8-DIMETHYL-2,4-DIOXO-4A,5-DIHYDROBENZO[G]PTERIDIN-10-YL]-2,3,4-TRIHYDROXY-PENTOXY]-HYDROXY-PHOSPHORYL] [(2R,3S,4R,5R)-5-(6-AMINOPURIN-9-YL)-3,4-DIHYDROXY-OXOLAN-2-YL]METHYLHYDROGEN PHOSPHATE
4XCG4Ligand/Ion2-(2-BENZOFURANYL)-2-IMIDAZOLINE

(-) Sites  (6, 6)

Asymmetric Unit (6, 6)
No.NameEvidenceResiduesDescription
1AC1SOFTWARELEU A:88 , PRO A:102 , LEU A:164 , PHE A:168 , ILE A:199 , THR A:201 , ILE A:316 , TYR A:326BINDING SITE FOR RESIDUE XCG A 602
2AC2SOFTWARETRP A:107 , ASP A:153 , LYS A:154 , CYS A:156 , HOH A:2145BINDING SITE FOR RESIDUE C15 A 603
3AC3SOFTWARELEU B:88 , PRO B:102 , LEU B:164 , ILE B:199 , THR B:201 , ILE B:316 , TYR B:326BINDING SITE FOR RESIDUE XCG B 602
4AC4SOFTWAREASP B:153 , LYS B:154 , CYS B:156BINDING SITE FOR RESIDUE C15 B 603
5AC5SOFTWAREVAL A:10 , GLY A:11 , GLY A:13 , ILE A:14 , SER A:15 , LEU A:33 , GLU A:34 , ALA A:35 , ARG A:36 , GLY A:40 , GLY A:41 , ARG A:42 , THR A:43 , GLY A:58 , SER A:59 , TYR A:60 , CYS A:172 , TYR A:188 , PRO A:234 , VAL A:235 , ALA A:263 , ILE A:264 , TRP A:388 , TYR A:393 , CYS A:397 , TYR A:398 , GLY A:425 , THR A:426 , GLY A:434 , TYR A:435 , MET A:436 , ALA A:439 , HOH A:2023 , HOH A:2027 , HOH A:2202 , HOH A:2290 , HOH A:2315 , HOH A:2351 , HOH A:2352 , HOH A:2353BINDING SITE FOR CHAIN A OF RESIDUES 600 TO 601
6AC6SOFTWAREGLY B:11 , GLY B:13 , ILE B:14 , SER B:15 , LEU B:33 , GLU B:34 , ALA B:35 , ARG B:36 , GLY B:40 , GLY B:41 , ARG B:42 , THR B:43 , GLY B:58 , SER B:59 , TYR B:60 , CYS B:172 , TYR B:188 , PRO B:234 , VAL B:235 , ALA B:263 , ILE B:264 , TRP B:388 , TYR B:393 , CYS B:397 , TYR B:398 , GLY B:425 , THR B:426 , GLY B:434 , TYR B:435 , MET B:436 , ALA B:439 , HOH B:2039 , HOH B:2068 , HOH B:2329 , HOH B:2397 , HOH B:2398 , HOH B:2399 , HOH B:2400 , HOH B:2401BINDING SITE FOR CHAIN B OF RESIDUES 600 TO 601

(-) SS Bonds  (0, 0)

(no "SS Bond" information available for 2XCG)

(-) Cis Peptide Bonds  (4, 4)

Asymmetric Unit
No.Residues
1Asn A:275 -Pro A:276
2Cys A:397 -Tyr A:398
3Asn B:275 -Pro B:276
4Cys B:397 -Tyr B:398

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (0, 0)

(no "SAP(SNP)/Variant" information available for 2XCG)

(-) PROSITE Motifs  (0, 0)

(no "PROSITE Motif" information available for 2XCG)

(-) Exons   (15, 30)

Asymmetric Unit (15, 30)
 ENSEMBLUniProtKBPDB
No.Transcript IDExonExon IDGenome LocationLengthIDLocationLengthCountLocationLength
1.1aENST000003780691aENSE00001476175X:43741693-43741500194AOFB_HUMAN1-16162A:3-16
B:3-16
14
14
1.4ENST000003780694ENSE00000847672X:43703010-4370291695AOFB_HUMAN16-47322A:16-47
B:16-47
32
32
1.5ENST000003780695ENSE00000386774X:43698251-43698114138AOFB_HUMAN48-93462A:48-93
B:48-93
46
46
1.6ENST000003780696ENSE00001035779X:43662651-43662547105AOFB_HUMAN94-128352A:94-128
B:94-128
35
35
1.7ENST000003780697ENSE00001035776X:43661510-4366141992AOFB_HUMAN129-159312A:129-159
B:129-159
31
31
1.8bENST000003780698bENSE00001035764X:43656513-43656372142AOFB_HUMAN159-206482A:159-206
B:159-206
48
48
1.9ENST000003780699ENSE00001035777X:43655135-43654986150AOFB_HUMAN207-256502A:207-256
B:207-256
50
50
1.10ENST0000037806910ENSE00001035772X:43652825-43652666160AOFB_HUMAN257-310542A:257-310
B:257-310
54
54
1.11ENST0000037806911ENSE00001035775X:43640791-4364069597AOFB_HUMAN310-342332A:310-342
B:310-342
33
33
1.12ENST0000037806912ENSE00001035768X:43639642-4363958954AOFB_HUMAN342-360192A:342-360
B:342-360
19
19
1.13ENST0000037806913ENSE00001035781X:43637986-4363792958AOFB_HUMAN360-379202A:360-379
B:360-379
20
20
1.14ENST0000037806914ENSE00001700569X:43634519-4363442298AOFB_HUMAN380-412332A:380-412
B:380-412
33
33
1.15aENST0000037806915aENSE00001712216X:43628665-43628554112AOFB_HUMAN412-449382A:412-449
B:412-449
38
38
1.16ENST0000037806916ENSE00000668638X:43627963-4362790163AOFB_HUMAN450-470212A:450-470
B:450-470
21
21
1.17bENST0000037806917bENSE00001332403X:43626865-436258581008AOFB_HUMAN471-520502A:471-501
B:471-496
31
26

(-) Sequences/Alignments

Asymmetric Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain A from PDB  Type:PROTEIN  Length:499
 aligned with AOFB_HUMAN | P27338 from UniProtKB/Swiss-Prot  Length:520

    Alignment length:499
                                    12        22        32        42        52        62        72        82        92       102       112       122       132       142       152       162       172       182       192       202       212       222       232       242       252       262       272       282       292       302       312       322       332       342       352       362       372       382       392       402       412       422       432       442       452       462       472       482       492         
           AOFB_HUMAN     3 NKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQKVKYVDLGGSYVGPTQNRILRLAKELGLETYKVNEVERLIHHVKGKSYPFRGPFPPVWNPITYLDHNNFWRTMDDMGREIPSDAPWKAPLAEEWDNMTMKELLDKLCWTESAKQLATLFVNLCVTAETHEVSALWFLWYVKQCGGTTRIISTTNGGQERKFVGGSGQVSERIMDLLGDRVKLERPVIYIDQTRENVLVETLNHEMYEAKYVISAIPPTLGMKIHFNPPLPMMRNQMITRVPLGSVIKCIVYYKEPFWRKKDYCGTMIIDGEEAPVAYTLDDTKPEGNYAAIMGFILAHKARKLARLTKEERLKKLCELYAKVLGSLEALEPVHYEEKNWCEEQYSGGCYTTYFPPGILTQYGRVLRQPVDRIYFAGTETATHWSGYMEGAVEAGERAAREILHAMGKIPEDEIWQSEPESVDVPAQPITTTFLERHLPSVPGLLRLIGLTTI 501
               SCOP domains d2xcga1 A:3-289,A:402-501 Monoamine oxidase B                                                                                                                                                                                                                                                  d2xcga2 A:290-401 Monoamine oxidase B                                                                           d2xcga1 A:3-289,A:402-501 Monoamine oxidase B                                                        SCOP domains
               CATH domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ....eeee..hhhhhhhhhhhhhh...eeeee..........ee.......ee....ee...hhhhhhhhhhh...eee.....eeeeee..eeeee........hhhhhhhhhhhhhhhhhhhh.....hhhhh.hhhhhhh.hhhhhhhhhh.hhhhhhhhhhhhhhhhh......hhhhhhhhhhh..hhhhhhh.......eee...hhhhhhhhhhhhh..eee...eeeee.....eeeee....eeee.eeee..hhhhhhhheee...hhhhhhhh.......eeeeeee...hhhhhh.eeeeeee........eeee.........eeeeeeehhhhhhhh..hhhhhhhhhhhhhhhhhhhhhhhh..eeeeee.hhh.............hhhhhhhhhh......eee.hhhhh.....hhhhhhhhhhhhhhhhhhhh...hhhhh.................hhhhhhh.hhhhhhhhhhhhh. Sec.struct. author
                 SAPs(SNPs) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                    PROSITE ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.1a     -------------------------------Exon 1.5  PDB: A:48-93 UniProt: 48-93         Exon 1.6  PDB: A:94-128            Exon 1.7  PDB: A:129-159       -----------------------------------------------Exon 1.9  PDB: A:207-256 UniProt: 207-256         Exon 1.10  PDB: A:257-310 UniProt: 257-310            -------------------------------Exon 1.12          -------------------Exon 1.14  PDB: A:380-412        -------------------------------------Exon 1.16            Exon 1.17b  PDB: A:471-501      Transcript 1 (1)
           Transcript 1 (2) -------------Exon 1.4  PDB: A:16-47          ---------------------------------------------------------------------------------------------------------------Exon 1.8b  PDB: A:159-206 UniProt: 159-206      -------------------------------------------------------------------------------------------------------Exon 1.11  PDB: A:310-342        -----------------Exon 1.13           --------------------------------Exon 1.15a  PDB: A:412-449            ---------------------------------------------------- Transcript 1 (2)
                 2xcg A   3 NKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQKVKYVDLGGSYVGPTQNRILRLAKELGLETYKVNEVERLIHHVKGKSYPFRGPFPPVWNPITYLDHNNFWRTMDDMGREIPSDAPWKAPLAEEWDNMTMKELLDKLCWTESAKQLATLFVNLCVTAETHEVSALWFLWYVKQCGGTTRIISTTNGGQERKFVGGSGQVSERIMDLLGDRVKLERPVIYIDQTRENVLVETLNHEMYEAKYVISAIPPTLGMKIHFNPPLPMMRNQMITRVPLGSVIKCIVYYKEPFWRKKDYCGTMIIDGEEAPVAYTLDDTKPEGNYAAIMGFILAHKARKLARLTKEERLKKLCELYAKVLGSLEALEPVHYEEKNWCEEQYSGGCYTTYFPPGILTQYGRVLRQPVDRIYFAGTETATHWSGYMEGAVEAGERAAREILHAMGKIPEDEIWQSEPESVDVPAQPITTTFLERHLPSVPGLLRLIGLTTI 501
                                    12        22        32        42        52        62        72        82        92       102       112       122       132       142       152       162       172       182       192       202       212       222       232       242       252       262       272       282       292       302       312       322       332       342       352       362       372       382       392       402       412       422       432       442       452       462       472       482       492         

Chain B from PDB  Type:PROTEIN  Length:494
 aligned with AOFB_HUMAN | P27338 from UniProtKB/Swiss-Prot  Length:520

    Alignment length:494
                                    12        22        32        42        52        62        72        82        92       102       112       122       132       142       152       162       172       182       192       202       212       222       232       242       252       262       272       282       292       302       312       322       332       342       352       362       372       382       392       402       412       422       432       442       452       462       472       482       492    
           AOFB_HUMAN     3 NKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQKVKYVDLGGSYVGPTQNRILRLAKELGLETYKVNEVERLIHHVKGKSYPFRGPFPPVWNPITYLDHNNFWRTMDDMGREIPSDAPWKAPLAEEWDNMTMKELLDKLCWTESAKQLATLFVNLCVTAETHEVSALWFLWYVKQCGGTTRIISTTNGGQERKFVGGSGQVSERIMDLLGDRVKLERPVIYIDQTRENVLVETLNHEMYEAKYVISAIPPTLGMKIHFNPPLPMMRNQMITRVPLGSVIKCIVYYKEPFWRKKDYCGTMIIDGEEAPVAYTLDDTKPEGNYAAIMGFILAHKARKLARLTKEERLKKLCELYAKVLGSLEALEPVHYEEKNWCEEQYSGGCYTTYFPPGILTQYGRVLRQPVDRIYFAGTETATHWSGYMEGAVEAGERAAREILHAMGKIPEDEIWQSEPESVDVPAQPITTTFLERHLPSVPGLLRLI 496
               SCOP domains d2xcgb1 B:3-289,B:402-496 Monoamine oxidase B                                                                                                                                                                                                                                                  d2xcgb2 B:290-401 Monoamine oxidase B                                                                           d2xcgb1 B:3-289,B:402-496 Monoamine oxidase B                                                   SCOP domains
               CATH domains -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
           Pfam domains (1) -----------Amino_oxidase-2xcgB01 B:14-451                                                                                                                                                                                                                                                                                                                                                                                                                        --------------------------------------------- Pfam domains (1)
           Pfam domains (2) -----------Amino_oxidase-2xcgB02 B:14-451                                                                                                                                                                                                                                                                                                                                                                                                                        --------------------------------------------- Pfam domains (2)
         Sec.struct. author ....eeee..hhhhhhhhhhhhhh...eeeee..........eeee...eeee....ee...hhhhhhhhhhh...eee.....eeeeee..eeeee........hhhhhhhhhhhhhhhhhhhh.....hhhhh.hhhhhhh.hhhhhhhhhh.hhhhhhhhhhhhhhhhh......hhhhhhhhhhh..hhhhhhh.......eee....hhhhhhhhhhhh..eee...eeeee.....eeeee....eeee.eeee..hhhhhhhheee...hhhhhhhh.......eeeeeee...hhhhhh.eeeeeee........eeee.........eeeeeeehhhhhhhh..hhhhhhhhhhhhhhhhhhhhhhhh..eeeeee.hhh.............hhhhhhhhhh......eee.hhhhh.....hhhhhhhhhhhhhhhhhhhh...hhhhh.................hhhhhhh.hhhhhhhh. Sec.struct. author
                 SAPs(SNPs) -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                    PROSITE -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.1a     -------------------------------Exon 1.5  PDB: B:48-93 UniProt: 48-93         Exon 1.6  PDB: B:94-128            Exon 1.7  PDB: B:129-159       -----------------------------------------------Exon 1.9  PDB: B:207-256 UniProt: 207-256         Exon 1.10  PDB: B:257-310 UniProt: 257-310            -------------------------------Exon 1.12          -------------------Exon 1.14  PDB: B:380-412        -------------------------------------Exon 1.16            Exon 1.17b  PDB: B:471-496 Transcript 1 (1)
           Transcript 1 (2) -------------Exon 1.4  PDB: B:16-47          ---------------------------------------------------------------------------------------------------------------Exon 1.8b  PDB: B:159-206 UniProt: 159-206      -------------------------------------------------------------------------------------------------------Exon 1.11  PDB: B:310-342        -----------------Exon 1.13           --------------------------------Exon 1.15a  PDB: B:412-449            ----------------------------------------------- Transcript 1 (2)
                 2xcg B   3 NKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQKVKYVDLGGSYVGPTQNRILRLAKELGLETYKVNEVERLIHHVKGKSYPFRGPFPPVWNPITYLDHNNFWRTMDDMGREIPSDAPWKAPLAEEWDNMTMKELLDKLCWTESAKQLATLFVNLCVTAETHEVSALWFLWYVKQCGGTTRIISTTNGGQERKFVGGSGQVSERIMDLLGDRVKLERPVIYIDQTRENVLVETLNHEMYEAKYVISAIPPTLGMKIHFNPPLPMMRNQMITRVPLGSVIKCIVYYKEPFWRKKDYCGTMIIDGEEAPVAYTLDDTKPEGNYAAIMGFILAHKARKLARLTKEERLKKLCELYAKVLGSLEALEPVHYEEKNWCEEQYSGGCYTTYFPPGILTQYGRVLRQPVDRIYFAGTETATHWSGYMEGAVEAGERAAREILHAMGKIPEDEIWQSEPESVDVPAQPITTTFLERHLPSVPGLLRLI 496
                                    12        22        32        42        52        62        72        82        92       102       112       122       132       142       152       162       172       182       192       202       212       222       232       242       252       262       272       282       292       302       312       322       332       342       352       362       372       382       392       402       412       422       432       442       452       462       472       482       492    

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (2, 4)

Asymmetric Unit

(-) CATH Domains  (0, 0)

(no "CATH Domain" information available for 2XCG)

(-) Pfam Domains  (1, 2)

Asymmetric Unit

(-) Gene Ontology  (26, 26)

Asymmetric Unit(hide GO term definitions)
Chain A,B   (AOFB_HUMAN | P27338)
molecular function
    GO:0009055    electron carrier activity    Any molecular entity that serves as an electron acceptor and electron donor in an electron transport chain. An electron transport chain is a process in which a series of electron carriers operate together to transfer electrons from donors to any of several different terminal electron acceptors to generate a transmembrane electrochemical gradient.
    GO:0050660    flavin adenine dinucleotide binding    Interacting selectively and non-covalently with FAD, flavin-adenine dinucleotide, the coenzyme or the prosthetic group of various flavoprotein oxidoreductase enzymes, in either the oxidized form, FAD, or the reduced form, FADH2.
    GO:0016491    oxidoreductase activity    Catalysis of an oxidation-reduction (redox) reaction, a reversible chemical reaction in which the oxidation state of an atom or atoms within a molecule is altered. One substrate acts as a hydrogen or electron donor and becomes oxidized, while the other acts as hydrogen or electron acceptor and becomes reduced.
    GO:0008131    primary amine oxidase activity    Catalysis of the reaction: a primary amine + H2O + O2 = an aldehyde + NH3 + hydrogen peroxide.
    GO:0042803    protein homodimerization activity    Interacting selectively and non-covalently with an identical protein to form a homodimer.
biological process
    GO:0042420    dopamine catabolic process    The chemical reactions and pathways resulting in the breakdown of dopamine, a catecholamine neurotransmitter and a metabolic precursor of noradrenaline and adrenaline.
    GO:0050665    hydrogen peroxide biosynthetic process    The chemical reactions and pathways resulting in the formation of hydrogen peroxide (H2O2), a potentially harmful byproduct of aerobic cellular respiration which can cause damage to DNA.
    GO:0014063    negative regulation of serotonin secretion    Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of serotonin.
    GO:0055114    oxidation-reduction process    A metabolic process that results in the removal or addition of one or more electrons to or from a substance, with or without the concomitant removal or addition of a proton or protons.
    GO:0045964    positive regulation of dopamine metabolic process    Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving dopamine.
    GO:0010044    response to aluminum ion    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an aluminum ion stimulus.
    GO:0051412    response to corticosterone    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a corticosterone stimulus. Corticosterone is a 21 carbon steroid hormone of the corticosteroid type, produced in the cortex of the adrenal glands. In many species, corticosterone is the principal glucocorticoid, involved in regulation of fuel metabolism, immune reactions, and stress responses.
    GO:0042493    response to drug    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
    GO:0045471    response to ethanol    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ethanol stimulus.
    GO:0032496    response to lipopolysaccharide    Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
    GO:0010269    response to selenium ion    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from selenium ion.
    GO:0048545    response to steroid hormone    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a steroid hormone stimulus.
    GO:0009636    response to toxic substance    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a toxic stimulus.
    GO:0021762    substantia nigra development    The progression of the substantia nigra over time from its initial formation until its mature state. The substantia nigra is the layer of gray substance that separates the posterior parts of the cerebral peduncles (tegmentum mesencephali) from the anterior parts; it normally includes a posterior compact part with many pigmented cells (pars compacta) and an anterior reticular part whose cells contain little pigment (pars reticularis).
cellular component
    GO:0070062    extracellular exosome    A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
    GO:0016021    integral component of membrane    The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
    GO:0016020    membrane    A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
    GO:0005740    mitochondrial envelope    The double lipid bilayer enclosing the mitochondrion and separating its contents from the cell cytoplasm; includes the intermembrane space.
    GO:0005743    mitochondrial inner membrane    The inner, i.e. lumen-facing, lipid bilayer of the mitochondrial envelope. It is highly folded to form cristae.
    GO:0005741    mitochondrial outer membrane    The outer, i.e. cytoplasm-facing, lipid bilayer of the mitochondrial envelope.
    GO:0005739    mitochondrion    A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.

 Visualization

(-) Interactive Views

Asymmetric Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
    3PL  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    C15  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    FA8  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    XCG  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
 
  Sites
    AC1  [ RasMol ]  +environment [ RasMol ]
    AC2  [ RasMol ]  +environment [ RasMol ]
    AC3  [ RasMol ]  +environment [ RasMol ]
    AC4  [ RasMol ]  +environment [ RasMol ]
    AC5  [ RasMol ]  +environment [ RasMol ]
    AC6  [ RasMol ]  +environment [ RasMol ]
 
  Cis Peptide Bonds
    Asn A:275 - Pro A:276   [ RasMol ]  
    Asn B:275 - Pro B:276   [ RasMol ]  
    Cys A:397 - Tyr A:398   [ RasMol ]  
    Cys B:397 - Tyr B:398   [ RasMol ]  
 
Biological Units
  Complete Structure
    Biological Unit 1  [ Jena3D ]
    Biological Unit 2  [ Jena3D ]

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  2xcg
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  AOFB_HUMAN | P27338
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  1.4.3.4
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  (no 'MIM ID' available)
    Disease InformationOMIM
 
Access by GenAge ID
  (no 'GenAge ID' available)
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  AOFB_HUMAN | P27338
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        AOFB_HUMAN | P273381gos 1h8r 1oj9 1oja 1ojc 1ojd 1s2q 1s2y 1s3b 1s3e 2bk3 2bk4 2bk5 2byb 2c64 2c65 2c66 2c67 2c70 2c72 2c73 2c75 2c76 2v5z 2v60 2v61 2vrl 2vrm 2vz2 2xfn 2xfo 2xfp 2xfq 2xfu 3po7 3zyx 4a79 4a7a 4crt 5mrl

(-) Related Entries Specified in the PDB File

1gos HUMAN MONOAMINE OXIDASE B
1h8r HUMAN MONOAMINE OXIDASE TYPE B (TRUNCATED)
1oj9 HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH 1,4-DIPHENYL-2-BUTENE
1oja HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH ISATIN
1ojb HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH TRANYLCYPROMINE
1ojc HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH N-(2-AMINOETHYL)-P-CHLOROBENZAMIDE
1ojd HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH LAURYLDIMETHYLAMINE-N-OXIDE (LDAO)
1s2q CRYSTAL STRUCTURE OF MAOB IN COMPLEX WITH N-PROPARGYL-1(R)-AMINOINDAN (RASAGILINE)
1s2y CRYSTAL STRUCTURE OF MAOB IN COMPLEX WITH N-PROPARGYL-1(S)-AMINOINDAN
1s3b CRYSTAL STRUCTURE OF MAOB IN COMPLEX WITH N-METHYL-N-PROPARGYL-1(R)-AMINOINDAN
1s3e CRYSTAL STRUCTURE OF MAOB IN COMPLEX WITH 6-HYDROXY-N-PROPARGYL-1(R)-AMINOINDAN
2bk3 HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH FARNESOL
2bk4 HUMAN MONOAMINE OXIDASE B: I199F MUTANT IN COMPLEX WITH RASAGILINE
2bk5 HUMAN MONOAMINE OXIDASE B: I199F MUTANT IN COMPLEX WITH ISATIN
2byb HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH DEPRENYL
2c64 MAO INHIBITION BY RASAGILINE ANALOGUES
2c65 MAO INHIBITION BY RASAGILINE ANALOGUES
2c66 MAO INHIBITION BY RASAGILINE ANALOGUES
2c67 MAO INHIBITION BY RASAGILINE ANALOGUES
2c70 FUNCTIONAL ROLE OF THE AROMATIC CAGE IN HUMAN MONOAMINE OXIDASE B: STRUCTURES AND CATALYTIC PROPERTIES OF TYR435 MUTANT PROTEINS
2c72 FUNCTIONAL ROLE OF THE AROMATIC CAGE IN HUMAN MONOAMINE OXIDASE B: STRUCTURES AND CATALYTIC PROPERTIES OF TYR435 MUTANT PROTEINS
2c73 FUNCTIONAL ROLE OF THE AROMATIC CAGE IN HUMAN MONOAMINE OXIDASE B: STRUCTURES AND CATALYTIC PROPERTIES OF TYR435 MUTANT PROTEINS
2c75 FUNCTIONAL ROLE OF THE AROMATIC CAGE IN HUMAN MONOAMINE OXIDASE B: STRUCTURES AND CATALYTIC PROPERTIES OF TYR435 MUTANT PROTEINS
2c76 FUNCTIONAL ROLE OF THE AROMATIC CAGE IN HUMAN MONOAMINE OXIDASE B: STRUCTURES AND CATALYTIC PROPERTIES OF TYR435 MUTANT PROTEINS
2v5z STRUCTURE OF HUMAN MAO B IN COMPLEX WITH THE SELECTIVE INHIBITOR SAFINAMIDE
2v60 STRUCTURE OF HUMAN MAO B IN COMPLEX WITH THE SELECTIVE INHIBITOR 7-(3-CHLOROBENZYLOXY )-4-CARBOXALDEHYDE-COUMARIN
2v61 STRUCTURE OF HUMAN MAO B IN COMPLEX WITH THE SELECTIVE INHIBITOR 7-(3-CHLOROBENZYLOXY )-4-(METHYLAMINO)METHYL-COUMARIN
2vrl STRUCTURE OF HUMAN MAO B IN COMPLEX WITH BENZYLHYDRAZINE
2vrm STRUCTURE OF HUMAN MAO B IN COMPLEX WITH PHENYETHYLHYDRAZINE
2vz2 HUMAN MAO B IN COMPLEX WITH MOFEGILINE